Discontinued — last reported Q4 '24
Restasis — Net revenues
AbbVie Restasis — Net revenues increased by 442.9% to $114.00M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 10.9%, from $128.00M to $114.00M. Over 3 years (FY 2021 to FY 2024), Restasis — Net revenues shows a downward trend with a -44.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests strong market demand or successful lifecycle management, while a decrease often signals increased generic competition, market saturation, or a decline in the product's therapeutic relevance.
Detailed definition
This metric represents the total net sales generated by a specific pharmaceutical product line, accounting for gross sal...
Peer comparison
Comparable to product-specific revenue reporting in other pharmaceutical companies, often analyzed alongside patent expiry timelines and generic entry impact.
abbv_segment_restasis_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $327.00M | $319.00M | $364.00M | $246.00M | $168.00M | $142.00M | $110.00M | $92.00M | $99.00M | $117.00M | $128.00M | $57.00M | $32.00M | $21.00M | $114.00M |
| QoQ Change | — | -2.4% | +14.1% | -32.4% | -31.7% | -15.5% | -22.5% | -16.4% | +7.6% | +18.2% | +9.4% | -55.5% | -43.9% | -34.4% | +442.9% |
| YoY Change | — | — | — | — | -48.6% | -55.5% | -69.8% | -62.6% | -41.1% | -17.6% | +16.4% | -38.0% | -67.7% | -82.1% | -10.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's restasis — net revenues?
- AbbVie (ABBV) reported restasis — net revenues of $114.00M in Q4 2024.
- How has AbbVie's restasis — net revenues changed year-over-year?
- AbbVie's restasis — net revenues decreased by 10.9% year-over-year, from $128.00M to $114.00M.
- What is the long-term trend for AbbVie's restasis — net revenues?
- Over 3 years (2021 to 2024), AbbVie's restasis — net revenues has grown at a -44.2% compound annual growth rate (CAGR), from $1.29B to $224.00M.
- What does restasis — net revenues mean?
- The total net revenue generated from the sales of a specific pharmaceutical product.